Skip to main content
. 2021 Feb 25;44(1):102–162. doi: 10.1080/10790268.2021.1863738

Table 10.

Clinical Utility of Substance Use Disorder Screeners Compared with Diagnostic Assessment

Study Screening Measure Cut Point Sensitivity % Specificity % PPV NPV Prevalence % N
Smith et al., 2009171 Single-question alcohol screening test ≥1 0.82 0.79     11.5 286
Smith et al., 2010172 Single-question screening test for drug use and drug use disorders (illicit and nonmedical use of prescription drugs) ≥1 1.00 0.74     11.9 286
Brown and Rounds, 1995174 CAGE-AID ≥1 ≥2 0.79, 0.77 0.77, 0.85        
Brown et al., 2001175 TICS   0.79 0.78     23 434, 702
Bradley et al., 2007176 AUDIT-C for men and women   0.86, 0.73 0.89, 0.91        
Gryczynski et al., 2017176 TAPS   0.80, 0.85, 0.91, 0.85 0.92, 0.71, 0.89, 0.93 0.60, 0.44, 0.25, 0.49 0.97, 0.95, 1.0, 0.99 25, 14, 4, 17 1,995- 2,000

Abbreviations: PPV, positive predictive value; NPV, negative predictive value; CAGE-AID, CAGE Adapted to Include Drugs; TICS, Two-Item Conjoint Screening test; AUDIT-C, Alcohol Use Disorders Identification Test- Consumption; TAPS, Tobacco, Alcohol, Prescription Medication, and Other Substance use.